MedStream Programmable Infusion Pump 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Codman Neuro 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-08-27
  • 사례 출판 날짜
    2013-08-27
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: codman neuro medstream programmable infusion pump it has come to our attention that medical device manufacturer, codman neuro, depuy synthes (companies of johnson & johnson), has initiated a field safety corrective action concerning its medstream programmable infusion pump. the affected product codes are 91-4200, 91-4201, 91-4289 and 91-4290. the introduction of air into the pump reservoir during pump filling may be followed by a rapid expansion of the gas volume as air enters parts of the pump with lower pressure than the refill chamber. this will cause the drug infusion rate to exceed the programmed rate leading to drug overdose. baclofen overdose may have symptoms including muscular hypotonia, drowsiness, nausea, depressed level of consciousness, or coma; while morphine overdose may have symptoms including respiratory depression or failure, depressed consciousness, hallucinations, hypotension, nausea and vomiting, ileus and urinary retention. the manufacturer advises that following the proper fill technique will reduce the risk of air entering the system. as such, codman neuro is updating the medstream system instructions for use (ifu) and product training by adding a warning statement and additional clarifications to reinforce the proper filling technique, as detailed in the enclosed ifu table in their field safety notice sent to the affected users. all customers are asked to review the information and contact local codman neuro sales representative for additional support. furthermore, customers are advised that the following statement will be added to the medstream system ifu and to review the ifu table enclosed in the field safety notice: “air in the pump reservoir may cause the infusion rate to exceed the programmed rate leading to drug overdose. care should be taken to remove all air from the drug syringes and filling assembly prior to filling the pump reservoir. ensure that all filling components are primed with fluid and visually verify that there are no air bubbles in the filling assembly prior to filling the pump reservoir.” if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 27 august 2013.

Device

Manufacturer